contract development and manufacturing organization
- H
Pharmaceutical Company Sai Parenteral IPO Sees Strong Performance
New Delhi, April 2 Shares of Sai Parenteral, a diversified pharmaceutical formulation company, closed on Thursday with a premium of nearly 4 per cent against the issue price of Rs 392.The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE. During the day...- Himanshu
- Thread
- bse contract development and manufacturing organization equity shares financial markets global formulations india initial public offering (ipo) injectable products investment market valuation nse oral solid dosage formulations pharmaceutical formulation company sai parenteral stock market
- Replies: 0
- Forum: Business
- H
Sai Parenteral IPO: 41% Subscription on Day 2
New Delhi, March 25 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, saw 41 per cent subscription on the second day of the share sale on Wednesday.The IPO received bids for 30,82,788 shares against 75,22,486 shares on offer, according to...- Himanshu
- Thread
- anchor investors contract development and manufacturing organization equity shares global formulations initial public offering injectable products ipo subscription new delhi oral solid dosage formulations pharmaceutical formulation price band qualified institutional buyers retail individual investors sai parenteral's ltd
- Replies: 0
- Forum: Business
- H
Pharmaceutical IPO: Sai Parenteral's Initial Offering
Sai Parenteral’s IPO Receives 4% Subscription on First Day New Delhi, March 24 – The initial public offering (IPO) of Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, received a 4% subscription on Tuesday, the first day of bidding.Initial Bidding Figures According to...- Himanshu
- Thread
- capital markets contract development and manufacturing organization equity shares global formulations india initial public offering injectable products investment ipo subscription new delhi oral solid dosage formulations pharmaceutical formulation price band public offering sai parenteral
- Replies: 0
- Forum: Business